| Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia SB Dusetzina, AN Winn, GA Abel, HA Huskamp, NL Keating J Clin Oncol 32 (4), 306-311, 2014 | 571 | 2014 |
| Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications RN Naylor, PM John, AN Winn, D Carmody, SAW Greeley, LH Philipson, ... Diabetes care 37 (1), 202-209, 2014 | 151 | 2014 |
| The cost-effectiveness of continuous glucose monitoring in type 1 diabetes ES Huang, M O'Grady, A Basu, A Winn, P John, J Lee, D Meltzer, ... Diabetes Care 33 (6), 1269-1274, 2010 | 146 | 2010 |
| Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences PJ Lin, DM Kent, A Winn, JT Cohen, PJ Neumann Am J Manag Care 21 (1), e23-34, 2015 | 145 | 2015 |
| Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia AN Winn, KL Keating, SB Dusetzina Journal of Clinical Oncology, 2016 | 133 | 2016 |
| Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: the DIAMOND Randomized Trial W Wan, R Skandari, A Minc, AG Nathan, A Winn, P Zarei, M O’Grady, ... Diabetes Care, 2018 | 121 | 2018 |
| The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes SAW Greeley, PM John, AN Winn, J Ornelas, RB Lipton, LH Philipson, ... Diabetes Care 34 (3), 622-627, 2011 | 116 | 2011 |
| Supplemental Nutrition Assistance Program (SNAP) Benefit Cycles and Student Disciplinary Infractions L Gennetian, R Seshadri, N Hess, AN Winn, R Goerge Social Services Review 90 (3), 403-433, 2016 | 75 | 2016 |
| Cost-utility analysis of cancer prevention, treatment, and control: a systematic review AN Winn, DU Ekwueme, GP Guy Jr, PJ Neumann American journal of preventive medicine 50 (2), 241-248, 2016 | 72 | 2016 |
| First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists JG Choi, AN Winn, MR Skandari, MI Franco, EM Staab, J Alexander, ... Annals of Internal Medicine, 2022 | 68 | 2022 |
| Association of Use of Online Symptom Checkers With Patients’ Plans for Seeking Care AN Winn, M Somai, N Fergestrom, BH Crotty JAMA Network Open 2 (12), e1918561-e1918561, 2019 | 65 | 2019 |
| The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer AN Winn, SB Dusetzina Pharmacoepidemiology and drug safety 25 (8), 953-959, 2016 | 61 | 2016 |
| Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries M Aaron, W Aaron, D Stacie JAMA Intern Medicine, 2018 | 57 | 2018 |
| Clinician burnout during the COVID-19 pandemic before vaccine administration BK Bakken, AN Winn Journal of the American Pharmacists Association, 2021 | 54 | 2021 |
| Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter? E Aarnio, J Martikainen, AN Winn, R Huupponen, J Vahtera, ... Circulation Cardiovascular Quality and Outcomes, 2016 | 48 | 2016 |
| Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis K Doll, A Winn American Journal of Obstetrics and Gynecology, 2019 | 47 | 2019 |
| Out-of-pocket and health care spending changes for patients using orally administered anticancer therapy after adoption of state parity laws SB Dusetzina, HA Huskamp, AN Winn, E Basch, NL Keating JAMA oncology 4 (6), e173598-e173598, 2018 | 47 | 2018 |
| Cost-effectiveness of autologous hematopoietic stem cell transplantation for elderly patients with multiple myeloma using the Surveillance, Epidemiology, and End Results … GL Shah, AN Winn, PJ Lin, A Klein, KA Sprague, HP Smith, R Buchsbaum, ... Biology of Blood and Marrow Transplantation 21 (10), 1823-1829, 2015 | 47 | 2015 |
| Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence Y Zhong, PJ Lin, JT Cohen, AN Winn, PJ Neumann Value in Health 18 (2), 308-314, 2015 | 47 | 2015 |
| Individualized glycemic control for US adults with type 2 diabetes: a cost-effectiveness analysis N Laiteerapong, JM Cooper, MR Skandari, PM Clarke, AN Winn, ... Annals of internal medicine 168 (3), 170-178, 2018 | 45 | 2018 |
Stacie DusetzinaVanderbilt University Medical CenterZweryfikowany adres z vanderbilt.edu